{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T06:16:36Z","timestamp":1783577796761,"version":"3.55.0"},"reference-count":41,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T00:00:00Z","timestamp":1783555200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cardiovasc. Med."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Cardiovascular autonomic neuropathy (CAN), defined as impaired autonomic control of the cardiovascular system, is a highly prevalent yet frequently underdiagnosed microvascular complication of diabetes. The triglyceride-glucose (TyG) index, a well-validated surrogate marker of insulin resistance, may have considerable clinical relevance for CAN. Nevertheless, the association between the TyG index and CAN in patients with type 2 diabetes mellitus (T2DM) remains unclear.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A total of 230 hospitalized patients with T2DM were recruited from the Department of Endocrinology and Metabolism, Shanghai General Hospital. CAN status was evaluated using the cardiovascular autonomic reflex test (CART) and heart rate variability (HRV) measurements. Meanwhile, demographic characteristics and relevant clinical data were collected, and the TyG index was calculated based on fasting blood glucose and triglyceride levels for subsequent statistical analysis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      The prevalence of CAN in our cohort of 230 patients was 61.3% (141 cases). Patients with CAN exhibited a significantly higher TyG index compared to those without CAN. The TyG index demonstrated positive correlations with CART parameters (E:I difference,\n                      <jats:italic>r<\/jats:italic>\n                      \u2009=\u20090.301; Valsalva ratio,\n                      <jats:italic>r<\/jats:italic>\n                      \u2009=\u20090.362; 30:15 ratio,\n                      <jats:italic>r<\/jats:italic>\n                      \u2009=\u20090.166; BP change,\n                      <jats:italic>r<\/jats:italic>\n                      \u2009=\u20090.229; all\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&amp;lt;\u20090.05) and inverse correlations with HRV indices (SDNN,\n                      <jats:italic>r<\/jats:italic>\n                      \u2009=\u2009\u22120.257; RMSSD,\n                      <jats:italic>r<\/jats:italic>\n                      \u2009=\u2009\u22120.226; pNN50,\n                      <jats:italic>r<\/jats:italic>\n                      \u2009=\u2009\u22120.226; VLF,\n                      <jats:italic>r<\/jats:italic>\n                      \u2009=\u2009\u22120.221; LF,\n                      <jats:italic>r<\/jats:italic>\n                      \u2009=\u2009\u22120.253; HF,\n                      <jats:italic>r<\/jats:italic>\n                      \u2009=\u2009\u22120.212; TP,\n                      <jats:italic>r<\/jats:italic>\n                      \u2009=\u2009\u22120.249; all\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&amp;lt;\u20090.01). Moreover, after adjusting for demographic and metabolic confounders, the TyG index remained a significant independent predictor of CAN. ROC curve analysis indicated that the TyG index possesses favorable discriminatory power for CAN, with an AUC of 0.854 (95% CI: 0.796\u20130.911,\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&amp;lt;\u20090.001).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>The TyG index shows a distinct association with CAN assessment parameters. As a well-established, effective, and practical surrogate marker of IR, this finding highlights the clinical relevance of the TyG index in diabetes-related complications.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fcvm.2026.1829752","type":"journal-article","created":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T05:34:55Z","timestamp":1783575295000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Association of triglyceride glucose index with cardiovascular autonomic neuropathy in type 2 diabetes mellitus"],"prefix":"10.3389","volume":"13","author":[{"given":"Feijuan","family":"Kong","sequence":"first","affiliation":[{"name":"Department of Endocrinology and Metabolism, Shanghai General Hospital Affiliated to Medical College of Shanghai Jiao Tong University","place":["Shanghai, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziqi","family":"Wang","sequence":"additional","affiliation":[{"name":"School of Medicine, University of Electronic Science and Technology of China","place":["Chengdu, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiyu","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Metabolism, Shanghai General Hospital Affiliated to Medical College of Shanghai Jiao Tong University","place":["Shanghai, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingzhu","family":"Wu","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Metabolism, Shanghai General Hospital Affiliated to Medical College of Shanghai Jiao Tong University","place":["Shanghai, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shanshan","family":"Tang","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Metabolism, Shanghai General Hospital Affiliated to Medical College of Shanghai Jiao Tong University","place":["Shanghai, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingyu","family":"Gu","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Metabolism, Shanghai General Hospital Affiliated to Medical College of Shanghai Jiao Tong University","place":["Shanghai, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoying","family":"Ding","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Metabolism, Shanghai General Hospital Affiliated to Medical College of Shanghai Jiao Tong University","place":["Shanghai, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yufan","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Metabolism, Shanghai General Hospital Affiliated to Medical College of Shanghai Jiao Tong University","place":["Shanghai, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,7,9]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"146921","DOI":"10.1016\/j.gene.2022.146921","article-title":"Genetic risk score is associated with T2DM and diabetes complications risks","volume":"849","author":"Hubacek","year":"2023","journal-title":"Gene"},{"key":"B2","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/S2213-8587(25)00299-2","article-title":"11th edition of the IDF Diabetes Atlas: global, regional, and national diabetes prevalence estimates for 2024 and projections for 2050","volume":"14","author":"Genitsaridi","year":"2026","journal-title":"Lancet Diabetes Endocrinol"},{"key":"B3","doi-asserted-by":"publisher","first-page":"m997","DOI":"10.1136\/bmj.m997","article-title":"Prevalence of diabetes recorded in mainland China using 2018 diagnostic criteria from the American diabetes association: national cross sectional study","volume":"369","author":"Li","year":"2020","journal-title":"BMJ (Clinical Research ed)"},{"key":"B4","doi-asserted-by":"publisher","first-page":"102646","DOI":"10.1016\/j.autneu.2020.102646","article-title":"Cardiovascular autonomic neuropathy: a silent killer with long reach","volume":"225","author":"Ang","year":"2020","journal-title":"Auton Neurosci"},{"key":"B5","doi-asserted-by":"publisher","first-page":"108334","DOI":"10.1016\/j.jdiacomp.2022.108334","article-title":"The conundrum of diabetic neuropathies-past, present, and future","volume":"36","author":"Ang","year":"2022","journal-title":"J Diabetes Complicat"},{"key":"B6","doi-asserted-by":"publisher","first-page":"1487","DOI":"10.2337\/dc15-0081","article-title":"Prevalence of cardiovascular autonomic neuropathy in a cohort of patients with newly diagnosed type 2 diabetes: the verona newly diagnosed type 2 diabetes study (VNDS)","volume":"38","author":"Zoppini","year":"2015","journal-title":"Diabetes Care"},{"key":"B7","doi-asserted-by":"publisher","first-page":"1394","DOI":"10.1016\/j.clinthera.2022.09.002","article-title":"Cardiac autonomic neuropathy in type 1 and 2 diabetes: epidemiology, pathophysiology, and management","volume":"44","author":"Williams","year":"2022","journal-title":"Clin Ther"},{"key":"B8","doi-asserted-by":"publisher","first-page":"e2480","DOI":"10.1136\/bmjdrc-2021-002480","article-title":"Cardiac autonomic neuropathy and risk of cardiovascular disease and mortality in type 1 and type 2 diabetes: a meta-analysis","volume":"9","author":"Chowdhury","year":"2021","journal-title":"BMJ Open Diabetes Res Care"},{"key":"B9","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1007\/s00125-020-05316-z","article-title":"The prevalence of cardiac autonomic neuropathy in prediabetes: a systematic review","volume":"64","author":"Eleftheriadou","year":"2021","journal-title":"Diabetologia"},{"key":"B10","doi-asserted-by":"publisher","first-page":"1118","DOI":"10.1007\/s00125-015-3534-7","article-title":"Increased prevalence of cardiac autonomic dysfunction at different degrees of glucose intolerance in the general population: the KORA S4 survey","volume":"58","author":"Ziegler","year":"2015","journal-title":"Diabetologia"},{"key":"B11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.pharmthera.2008.05.005","article-title":"Diabetic neuropathy: mechanisms to management","volume":"120","author":"Edwards","year":"2008","journal-title":"Pharmacol Ther"},{"key":"B12","doi-asserted-by":"publisher","first-page":"9524635","DOI":"10.1155\/2020\/9524635","article-title":"Understanding diabetic neuropathy: focus on oxidative stress","volume":"2020","author":"Pang","year":"2020","journal-title":"Oxid Med Cell Longevity"},{"key":"B13","doi-asserted-by":"publisher","first-page":"101135","DOI":"10.1016\/j.cpcardiol.2022.101135","article-title":"Relation between glycemic control and cardiac autonomic neuropathy in patients with diabetes mellitus type 2","volume":"48","author":"Achmad","year":"2023","journal-title":"Curr Probl Cardiol"},{"key":"B14","doi-asserted-by":"publisher","first-page":"1995","DOI":"10.1007\/s13300-019-00693-0","article-title":"Cardiac autonomic neuropathy in obesity, the metabolic syndrome and prediabetes: a narrative review","volume":"10","author":"Williams","year":"2019","journal-title":"Diabetes Ther"},{"key":"B15","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/j.medcli.2022.07.003","article-title":"Diabetes mellitus prediction based on the triglyceride and glucose index","volume":"160","author":"Campos Mu\u00f1iz","year":"2023","journal-title":"Med Clin (Barc)"},{"key":"B16","doi-asserted-by":"publisher","first-page":"2838","DOI":"10.3390\/nu11112838","article-title":"Comparison of the effects of fasting glucose, hemoglobin A(1c), and triglyceride-glucose Index on cardiovascular events in type 2 diabetes Mellitus","volume":"11","author":"Su","year":"2019","journal-title":"Nutrients"},{"key":"B17","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1111\/jdi.13371","article-title":"Association between the triglyceride-glucose index and diabetic nephropathy in patients with type 2 diabetes: a cross-sectional study","volume":"12","author":"Liu","year":"2021","journal-title":"J Diabetes Investig"},{"key":"B18","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1186\/s12933-024-02228-9","article-title":"Associations between cardiometabolic indices and the risk of diabetic kidney disease in patients with type 2 diabetes","volume":"23","author":"Yan","year":"2024","journal-title":"Cardiovasc Diabetol"},{"key":"B19","doi-asserted-by":"publisher","first-page":"1487","DOI":"10.1111\/jdi.70086","article-title":"The cholesterol-HDL-glucose (CHG) index and traditional adiposity markers in predicting diabetic retinopathy and nephropathy","volume":"16","author":"\u00c7atak","year":"2025","journal-title":"J Diabetes Investig"},{"key":"B20","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1186\/s12944-024-02249-z","article-title":"Non-linear association of triglyceride-glucose index with cardiovascular and all-cause mortality in T2DM patients with diabetic kidney disease: NHANES 2001\u22122018 retrospective cohort study","volume":"23","author":"Zhang","year":"2024","journal-title":"Lipids Health Dis"},{"key":"B21","doi-asserted-by":"publisher","first-page":"3","DOI":"10.4093\/dmj.2018.0259","article-title":"Update on the impact, diagnosis and management of cardiovascular autonomic neuropathy in diabetes: what is defined, what is new, and what is unmet","volume":"43","author":"Spallone","year":"2019","journal-title":"Diabetes Metab J"},{"key":"B22","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1186\/s12933-024-02185-3","article-title":"Prevalence and prognostic significance of cardiac autonomic neuropathy in community-based people with type 2 diabetes: the fremantle diabetes study phase II","volume":"23","author":"Davis","year":"2024","journal-title":"Cardiovasc Diabetol"},{"key":"B23","doi-asserted-by":"publisher","first-page":"94","DOI":"10.2337\/dc16-1397","article-title":"Cardiovascular autonomic neuropathy and cardiovascular outcomes in the diabetes control and complications trial\/epidemiology of diabetes interventions and complications (DCCT\/EDIC) study","volume":"40","author":"Pop-Busui","year":"2017","journal-title":"Diabetes Care"},{"key":"B24","doi-asserted-by":"publisher","first-page":"2942","DOI":"10.2337\/diacare.27.12.2942","article-title":"Autonomic symptoms and diabetic neuropathy: a population-based study","volume":"27","author":"Low","year":"2004","journal-title":"Diabetes Care"},{"key":"B25","doi-asserted-by":"publisher","first-page":"1068","DOI":"10.2337\/dc17-2062","article-title":"Risk factors for incident diabetic polyneuropathy in a cohort with screen-detected type 2 diabetes followed for 13 years: ADDITION-Denmark","volume":"41","author":"Andersen","year":"2018","journal-title":"Diabetes Care"},{"key":"B26","doi-asserted-by":"publisher","first-page":"108235","DOI":"10.1016\/j.diabres.2020.108235","article-title":"Prevalence of microvascular and macrovascular disease in the glycemia reduction approaches in diabetes\u2014a comparative effectiveness (GRADE) study cohort","volume":"165","author":"Mather","year":"2020","journal-title":"Diabetes Res Clin Pract"},{"key":"B27","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1111\/pedi.12633","article-title":"Cardiovascular autonomic neuropathy in adolescents and young adults with type 1 and type 2 diabetes: the SEARCH for diabetes in youth cohort study","volume":"19","author":"Jaiswal","year":"2018","journal-title":"Pediatr Diabetes"},{"key":"B28","doi-asserted-by":"publisher","first-page":"1670","DOI":"10.2337\/dci22-0014","article-title":"Heart failure: an underappreciated complication of diabetes. A consensus report of the American diabetes association","volume":"45","author":"Pop-Busui","year":"2022","journal-title":"Diabetes Care"},{"key":"B29","doi-asserted-by":"publisher","first-page":"334","DOI":"10.2337\/diacare.29.02.06.dc05-1242","article-title":"Cardiac autonomic neuropathy predicts cardiovascular morbidity and mortality in type 1 diabetic patients with diabetic nephropathy","volume":"29","author":"Astrup","year":"2006","journal-title":"Diabetes Care"},{"key":"B30","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1212\/WNL.49.1.229","article-title":"Longitudinal assessment of diabetic polyneuropathy using a composite score in the Rochester diabetic neuropathy study cohort","volume":"49","author":"Dyck","year":"1997","journal-title":"Neurology"},{"key":"B31","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.1007\/s00125-006-0169-8","article-title":"Remote neurotrophic support of epidermal nerve fibres in experimental diabetes","volume":"49","author":"Toth","year":"2006","journal-title":"Diabetologia"},{"key":"B32","doi-asserted-by":"publisher","first-page":"184","DOI":"10.2337\/db21-0490","article-title":"Metabolic and metabo-clinical signatures of type 2 diabetes, obesity, retinopathy, and dyslipidemia","volume":"71","author":"Yousri","year":"2022","journal-title":"Diabetes"},{"key":"B33","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.3346\/jkms.2017.32.7.1131","article-title":"Potential association of triglyceride glucose Index with cardiac autonomic neuropathy in type 2 diabetes Mellitus patients","volume":"32","author":"Akbar","year":"2017","journal-title":"J Korean Med Sci"},{"key":"B34","doi-asserted-by":"publisher","first-page":"e42541","DOI":"10.7759\/cureus.42541","article-title":"Assessment of triglyceride glucose index in type 2 diabetes mellitus patients with and without cardiac autonomic neuropathy","volume":"15","author":"Jeyaseeli","year":"2023","journal-title":"Cureus"},{"key":"B35","doi-asserted-by":"publisher","first-page":"986","DOI":"10.47391\/JPMA.22-63","article-title":"Triglyceride glucose (TyG) Index: a surrogate biomarker of insulin resistance","volume":"72","author":"Ramdas Nayak","year":"2022","journal-title":"J Pak Med Assoc"},{"key":"B36","first-page":"873","article-title":"Assessment: clinical autonomic testing report of the therapeutics and technology assessment subcommittee of the American academy of neurology","volume":"46","year":"1996","journal-title":"Neurology"},{"key":"B37","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1186\/s12933-025-02622-x","article-title":"Association of baseline and trajectory of triglyceride-glucose index with the incidence of cardiovascular autonomic neuropathy in type 2 diabetes mellitus","volume":"24","author":"Huang","year":"2025","journal-title":"Cardiovasc Diabetol"},{"key":"B38","doi-asserted-by":"publisher","first-page":"1673","DOI":"10.1016\/j.metabol.2011.04.006","article-title":"Comparison of two methods using plasma triglyceride concentration as a surrogate estimate of insulin action in nondiabetic subjects: triglycerides\u00d7glucose versus triglyceride\/high-density lipoprotein cholesterol","volume":"60","author":"Abbasi","year":"2011","journal-title":"Metabolism"},{"key":"B39","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1186\/s12933-025-02674-z","article-title":"Can cardiovascular health and its modifiable healthy lifestyle offset the increased risk of all-cause and cardiovascular deaths associated with insulin resistance?","volume":"24","author":"Qiu","year":"2025","journal-title":"Cardiovasc Diabetol"},{"key":"B40","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/bs.vh.2024.02.007","article-title":"Advanced glycation end products and insulin resistance in diabetic nephropathy","volume":"125","author":"Parwani","year":"2024","journal-title":"Vitam Horm"},{"key":"B41","doi-asserted-by":"publisher","first-page":"e1705","DOI":"10.1097\/MD.0000000000001705","article-title":"Changes in metabolic health Status over time and risk of developing type 2 diabetes: a prospective cohort study","volume":"94","author":"Lee","year":"2015","journal-title":"Medicine (Baltimore)"}],"container-title":["Frontiers in Cardiovascular Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2026.1829752\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T05:34:55Z","timestamp":1783575295000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2026.1829752\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,9]]},"references-count":41,"alternative-id":["10.3389\/fcvm.2026.1829752"],"URL":"https:\/\/doi.org\/10.3389\/fcvm.2026.1829752","relation":{},"ISSN":["2297-055X"],"issn-type":[{"value":"2297-055X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,9]]},"article-number":"1829752"}}